|
"蘇美慈"的相關文件
顯示項目 6-15 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2019-12-01 |
Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia
|
蘇美慈; Su, Mei-Tsz; Wang, Chia-Yih;Tsai, Pei-Yin;Chen, Ting-Yu;Tsai, Hui-Ling;Kuo, Pao-Lin |
| 國立成功大學 |
2019-08-01 |
人類遺傳流行病學與基因體資料分析(一)
|
蘇美慈;張惠華;林聖翔;陳芃潔 |
| 國立成功大學 |
2019-06-15 |
Elevated miR-200a and miR-141 inhibit endocrine gland-derived vascular endothelial growth factor expression and ciliogenesis in preeclampsia
|
蘇美慈; Su, Mei-Tsz; Wang, Chia-Yih;Tsai, Pei-Yin;Chen, Ting-Yu;Tsai, Hui-Ling;Kuo, Pao-Lin |
| 國立成功大學 |
2019 |
微型核糖核酸200家族(miR-200 family)在姙娠子癲前症的角色及調控機轉
|
蘇美慈 |
| 臺大學術典藏 |
2018-09-10T08:45:11Z |
Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility
|
Lee, I.-W. and Kuo, P.-H. and Su, M.-T. and Kuan, L.-C. and Hsu, C.-C. and Kuo, P.-L.; 李逸文;郭柏秀;蘇美慈;關龍錦;許朝欽;郭保麟; LEE, I.-WEN;KUO, PO-HSIU;SU, MEI-TSZ;KUAN, LONG-CHING;HSU, CHAO-CHIN;KUO, PAO-LIN; PO-HSIU KUO; LEE, I.-WEN; KUO, PO-HSIU; SU, MEI-TSZ; KUAN, LONG-CHING; HSU, CHAO-CHIN; KUO, PAO-LIN |
| 臺大學術典藏 |
2018-09-10T08:17:14Z |
Quantitative trait analysis suggests human DAZL may be involved in regulating sperm counts and motility
|
HSU, CHAO-CHIN;KUO, PO-HSIU;LEE, I-WEN;SU, MEI-TSZ;TSENG, JOSEPH T.;KUO, PAO-LIN; PO-HSIU KUO; HSU, CHAO-CHIN; KUO, PO-HSIU; LEE, I-WEN; SU, MEI-TSZ; TSENG, JOSEPH T.; KUO, PAO-LIN; Hsu, C.-C. and Kuo, P.-H. and Lee, I.-W. and Su, M.-T. and Tseng, J.T. and Kuo, P.-L.; 許朝欽;郭柏秀;李逸文;蘇美慈;曾大千;郭保麟 |
| 國立成功大學 |
2018 |
探討胎球蛋白-A在妊娠糖尿病中胎盤發炎反應所扮演的角色
|
蔡佩穎;郭保麟;蘇美慈 |
| 國立成功大學 |
2018 |
微型核糖核酸200家族(miR-200 family)在姙娠子癲前症的角色及調控機轉
|
蘇美慈 |
| 國立成功大學 |
2017-06-01 |
Primary Cilium-Regulated EG-VEGF Signaling Facilitates Trophoblast Invasion
|
蘇美慈; Su, Mei-Tsz; Wang, Chia-Yih;Tsai, Hui-Ling;Syu, Jhih-Siang;Chen, Ting-Yu |
| 國立成功大學 |
2016 |
探討血清胎球蛋白-A在妊娠糖尿病所扮演的角色：對其胎盤發展的影響及胰島素敏感度之相關表現機轉
|
蔡佩穎;歐弘毅;蘇美慈 |
顯示項目 6-15 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
